254 related articles for article (PubMed ID: 29622904)
21. Olive oil lessened fatty liver severity independent of cardiometabolic correction in patients with non-alcoholic fatty liver disease: A randomized clinical trial.
Rezaei S; Akhlaghi M; Sasani MR; Barati Boldaji R
Nutrition; 2019 Jan; 57():154-161. PubMed ID: 30170304
[TBL] [Abstract][Full Text] [Related]
22. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
23. Prevalence and risk factors of nonalcoholic fatty liver disease in breast cancer patients.
Lee S; Jung Y; Bae Y; Yun SP; Kim S; Jo H; Seo HI
Tumori; 2017 Mar; 103(2):187-192. PubMed ID: 27647227
[TBL] [Abstract][Full Text] [Related]
24. Eating Fast Is Associated with Nonalcoholic Fatty Liver Disease in Men But Not in Women with Type 2 Diabetes: A Cross-Sectional Study.
Takahashi F; Hashimoto Y; Kawano R; Kaji A; Sakai R; Kawate Y; Okamura T; Ushigome E; Kitagawa N; Majima S; Sennmaru T; Okada H; Nakanishi N; Hamaguchi M; Asano M; Yamazaki M; Fukui M
Nutrients; 2020 Jul; 12(8):. PubMed ID: 32707957
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
[TBL] [Abstract][Full Text] [Related]
26. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients With Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease.
Euh W; Lim S; Kim JW
Front Endocrinol (Lausanne); 2021; 12():613389. PubMed ID: 34177796
[TBL] [Abstract][Full Text] [Related]
27. Female spontaneously diabetic Torii fatty rats develop nonalcoholic steatohepatitis-like hepatic lesions.
Ishii Y; Motohashi Y; Muramatsu M; Katsuda Y; Miyajima K; Sasase T; Yamada T; Matsui T; Kume S; Ohta T
World J Gastroenterol; 2015 Aug; 21(30):9067-78. PubMed ID: 26290633
[TBL] [Abstract][Full Text] [Related]
28. Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.
Endale HT; Mengstie TA; Dawit DD; Mohammed R; Dessie G; Tesfa KH
PLoS One; 2021; 16(11):e0260022. PubMed ID: 34797863
[TBL] [Abstract][Full Text] [Related]
29. Performance of non-invasive models of fibrosis in predicting mild to moderate fibrosis in patients with non-alcoholic fatty liver disease.
Siddiqui MS; Patidar KR; Boyett S; Luketic VA; Puri P; Sanyal AJ
Liver Int; 2016 Apr; 36(4):572-9. PubMed ID: 26713759
[TBL] [Abstract][Full Text] [Related]
30. The Symptoms of Gastroesophageal Reflux Disease Correlate with High Body Mass Index, the Aspartate Aminotransferase/Alanine Aminotransferase Ratio and Insulin Resistance in Japanese Patients with Non-alcoholic Fatty Liver Disease.
Fujiwara M; Eguchi Y; Fukumori N; Eguchi H; Tomonaga M; Yoshioka T; Hyakutake M; Sakanishi Y; Kyoraku I; Sugioka T; Fujimoto K; Kusano M; Yamashita S
Intern Med; 2015; 54(24):3099-104. PubMed ID: 26666594
[TBL] [Abstract][Full Text] [Related]
31. Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring.
Mantovani A; Rigamonti A; Bonapace S; Bolzan B; Pernigo M; Morani G; Franceschini L; Bergamini C; Bertolini L; Valbusa F; Rigolon R; Pichiri I; Zoppini G; Bonora E; Violi F; Targher G
Diabetes Care; 2016 Aug; 39(8):1416-23. PubMed ID: 27222503
[TBL] [Abstract][Full Text] [Related]
32. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
[TBL] [Abstract][Full Text] [Related]
33. The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials.
Jalali M; Rahimlou M; Mahmoodi M; Moosavian SP; Symonds ME; Jalali R; Zare M; Imanieh MH; Stasi C
Pharmacol Res; 2020 Sep; 159():104799. PubMed ID: 32278041
[TBL] [Abstract][Full Text] [Related]
34. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
Wang Z; Xu M; Hu Z; Shrestha UK
Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.
Zhang Y; He H; Zeng YP; Yang LD; Jia D; An ZM; Jia WG
Lipids Health Dis; 2020 Jun; 19(1):134. PubMed ID: 32527258
[TBL] [Abstract][Full Text] [Related]
37. Relationship between hypothyroidism and non-alcoholic fatty liver disease in the Spanish population.
Martínez Escudé A; Pera G; Arteaga I; Expósito C; Rodríguez L; Torán P; Caballeria L
Med Clin (Barc); 2020 Jan; 154(1):1-6. PubMed ID: 31153607
[TBL] [Abstract][Full Text] [Related]
38. Non-alcoholic fatty liver disease and the metabolic syndrome in an urban hospital serving an African community.
Onyekwere CA; Ogbera AO; Balogun BO
Ann Hepatol; 2011; 10(2):119-24. PubMed ID: 21502672
[TBL] [Abstract][Full Text] [Related]
39. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
[TBL] [Abstract][Full Text] [Related]
40. Application of Machine Learning Methods to Predict Non-Alcoholic Steatohepatitis (NASH) in Non-Alcoholic Fatty Liver (NAFL) Patients.
Fialoke S; Malarstig A; Miller MR; Dumitriu A
AMIA Annu Symp Proc; 2018; 2018():430-439. PubMed ID: 30815083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
